Piyush Garg

Piyush Garg

Auto-generated profile, based on publicly available information

Piyush Garg

Centre for Ocular Research & Education (CORE), School of Optometry & Vision Science, University of Waterloo, 200 University Avenue West, Waterloo N2L 3G1, ON, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Nano Today
Verified
Journal Article
Closed access
PGPiyush Garg
Piyush Garg
SSSujata Sangam
Sujata Sangam
DKDakshi Kochhar
Dakshi Kochhar
SPSiddhartha Pahari
Siddhartha Pahari
CKChirantan Kar
Chirantan Kar
MMMonalisa Mukherjee
Monalisa Mukherjee

23 November 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
PSPar Shokrollahi
Par Shokrollahi
PGPiyush Garg
Piyush Garg
DWDavid Wulff
David Wulff
AHAlex Hui
Alex Hui
Chau-Minh PhanChau-Minh Phan
Chau-Minh Phan
Lyndon JonesLyndon Jones
Lyndon Jones

17 December 2022 in Drug Delivery and Translational Research
Verified
Journal Article
Open access
PDF file
APAna F. Pereira-da-Mota
Ana F. Pereira-da-Mota
Maria Vivero-LopezMaria Vivero-Lopez
Maria Vivero-Lopez
PGPiyush Garg
Piyush Garg
Chau-Minh PhanChau-Minh Phan
Chau-Minh Phan
ACAngel Concheiro
Angel Concheiro
Carmen Alvarez-LorenzoCarmen Alvarez-Lorenzo
Carmen Alvarez-Lorenzo
There is still a paucity of information on how in vitro release profiles from drug-loaded contact lenses (CLs) recorded in 3D printed eye models correlate with in vivo profiles. This work aims to evaluate the release profiles of two drug-loaded CLs in a 3D in vitro eye blink model and compare the obtained results with the release in a vial and the drug levels in tear fluid previously obtained from an animal in vivo study. In vitro release in the eye model was tested at two different flow rates (5 and 10 µL/min) and a blink speed of 1 blink/10 s. Model CLs were loaded with two different drugs, hydrophilic pravastatin and hydrophobic resveratrol. The release of both drugs was more sustained and lower in the 3D eye model compared to the in vitro release in vials. Interestingly, both drugs presented similar release patterns in the eye model and in vivo, although the total amount of drugs released in the eye model was significantly lower, especially for resveratrol. Strong correlations between percentages of pravastatin released in the eye model and in vivo were found. These findings suggest that the current 3D printed eye blink model could be a useful tool to measure the release of ophthalmic drugs from medicated CLs. Nevertheless, physiological parameters such as the composition of the tear fluid and eyeball surface, tear flow rates, and temperature should be optimized in further studies. Graphical abstract

21 December 2024 in ACS Omega
Verified
Journal Article
Open access
PGPiyush Garg
Piyush Garg
PSParvin Shokrollahi
Parvin Shokrollahi
HDHaile Darge
Haile Darge
CPChau-Minh Phan
Chau-Minh Phan
Lyndon JonesLyndon Jones
Lyndon Jones
Dry eye disease is becoming increasingly prevalent, and lubricating eye drops, a mainstay of its treatment, have a short duration of time on the ocular surface. Although there are various drug delivery methods to increase the ocular surface residence time of a topical lubricant, the main problem is the burst release from these delivery systems. To overcome this limitation, herein, a chemical-physical interpenetrating network (IPN) was fabricated to take control over the release of poly(vinyl alcohol) (PVA), a well-known therapeutic agent used to stabilize tear film, from gelatin methacrylate (GelMA) hydrogels. In this report, PVA was specifically used as part of a GelMA-based polymeric hydrogel owing to its physical cross-linking ability via a simple freeze-thaw method. The interpenetrating polymer network was fabricated in a sequential manner where GelMA was chemically cross-linked by photo-cross-linking, followed by physical cross-linking of PVA using a relatively short freeze-thaw cycle. Interestingly, upon applying only one short freeze-thaw cycle (of 1 or 2 h), the crystalline domains in PVA were increased in the interpenetrating network. The endothermic peaks at 48 and 60 °C in differential scanning calorimetry (DSC) thermograms and 20°-2θ peaks in X-ray diffraction (XRD) patterns suggest the presence of these crystalline domains. With the help of a suite of characterization, we further delineate the role of freeze-thaw cycles in taking control over the release of PVA. The release profiles of the PVA-containing hydrogels showed highest linearity with the Korsmeyer-Peppas model (0.9944 < R 2 < 0.9952), indicating that these systems follow non-Fickian or anomalous transport.

15 November 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
BHBrandon Ho
Brandon Ho
Chau-Minh PhanChau-Minh Phan
Chau-Minh Phan
PGPiyush Garg
Piyush Garg
PSParvin Shokrollahi
Parvin Shokrollahi
Lyndon JonesLyndon Jones
Lyndon Jones
This study attempts to address the challenge of accurately measuring the degradation of biodegradable hydrogels, which are frequently employed in drug delivery for controlled and sustained release. The traditional method utilizes a mass-loss approach, which is cumbersome and time consuming. The aim of this study was to develop an innovative screening platform using a millifluidic device coupled with automated image analysis to measure the degradation of Gelatin methacrylate (GelMA) and the subsequent release of an entrapped wetting agent, polyvinyl alcohol (PVA). Gel samples were placed within circular wells on a custom millifluidic chip and stained with a red dye for enhanced visualization. A camera module captured time-lapse images of the gels throughout their degradation. An image-analysis algorithm was used to translate the image data into degradation rates. Simultaneously, the eluate from the chip was collected to quantify the amount of GelMA degraded and PVA released at various time points. The visual method was validated by comparing it with the mass-loss approach (R = 0.91), as well as the amount of GelMA eluted (R = 0.97). The degradation of the GelMA gels was also facilitated with matrix metalloproteinases 9. Notably, as the gels degraded, there was an increase in the amount of PVA released. Overall, these results support the use of the screening platform to assess hydrogel degradation and the subsequent release of entrapped therapeutic compounds.